JBM (Healthcare) Limited (HKG:2161)
Hong Kong · Delayed Price · Currency is HKD 1.920
0.00 (0.00%)
Jul 31, 2026, 3:30 PM HKT
JBM (Healthcare) Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,574 | 2,174 | 1,457 | 790 | 987 | 813 | |
Market Cap Growth | -35.54% | 49.21% | 84.51% | -19.97% | 21.34% | -32.09% |
Enterprise Value | 1,845 | 2,371 | 1,411 | 836 | 1,112 | 1,033 |
Last Close Price | 1.92 | 2.66 | 1.67 | 0.82 | 0.88 | 0.74 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 7.80 | 10.81 | 7.39 | 6.05 | 17.28 | 33.03 |
Forward PE | 7.30 | 8.23 | - | - | - | - |
PS Ratio | 1.89 | 2.61 | 1.86 | 1.22 | 1.90 | 2.00 |
PB Ratio | 1.39 | 1.92 | 1.25 | 0.77 | 0.96 | 0.84 |
P/TBV Ratio | 40.35 | 55.73 | 5.50 | 5.99 | 7.73 | 8.10 |
P/FCF Ratio | 12.19 | 16.84 | 7.08 | 4.36 | 7.18 | 15.36 |
P/OCF Ratio | 9.69 | 13.39 | 6.42 | 4.13 | 6.78 | 13.56 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.21 | 2.84 | 1.80 | 1.29 | 2.14 | 2.55 |
EV/EBITDA Ratio | 5.88 | 8.09 | 5.21 | 4.28 | 11.01 | 13.80 |
EV/EBIT Ratio | 6.98 | 8.98 | 6.04 | 5.16 | 15.77 | 25.02 |
EV/FCF Ratio | 14.29 | 18.36 | 6.85 | 4.62 | 8.09 | 19.52 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.35 | 0.35 | 0.15 | 0.13 | 0.18 | 0.22 |
Debt / EBITDA Ratio | 1.25 | 1.25 | 0.60 | 0.64 | 1.58 | 2.39 |
Debt / FCF Ratio | 3.05 | 3.05 | 0.83 | 0.74 | 1.31 | 4.03 |
Net Debt / Equity Ratio | 0.19 | 0.19 | -0.05 | -0.03 | 0.02 | 0.14 |
Net Debt / EBITDA Ratio | 0.75 | 0.75 | -0.23 | -0.17 | 0.17 | 1.79 |
Net Debt / FCF Ratio | 1.70 | 1.70 | -0.30 | -0.19 | 0.12 | 2.53 |
Asset Turnover | 0.51 | 0.51 | 0.53 | 0.47 | 0.38 | 0.30 |
Inventory Turnover | 4.55 | 4.55 | 4.24 | 4.25 | 6.15 | 5.10 |
Quick Ratio | 1.59 | 1.59 | 1.32 | 1.25 | 1.42 | 1.69 |
Current Ratio | 1.90 | 1.90 | 1.61 | 1.66 | 1.70 | 2.06 |
Return on Equity (ROE) | 18.33% | 18.33% | 18.55% | 13.37% | 6.33% | 2.44% |
Return on Assets (ROA) | 9.98% | 9.98% | 9.95% | 7.26% | 3.22% | 1.90% |
Return on Invested Capital (ROIC) | 16.31% | 17.97% | 18.75% | 13.26% | 5.40% | 2.83% |
Return on Capital Employed (ROCE) | 17.50% | 17.50% | 18.50% | 13.90% | 5.80% | 3.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 12.78% | 9.25% | 13.54% | 16.52% | 5.79% | 3.03% |
FCF Yield | 8.20% | 5.94% | 14.13% | 22.92% | 13.93% | 6.51% |
Dividend Yield | 8.91% | 6.43% | 10.20% | 9.12% | 3.40% | - |
Payout Ratio | 86.43% | 86.43% | 39.89% | 40.41% | 7.83% | - |
Buyback Yield / Dilution | 0.32% | 0.32% | 7.30% | 0.86% | 0.26% | -9.79% |
Total Shareholder Return | 9.23% | 6.75% | 17.50% | 9.98% | 3.65% | -9.79% |